Literature DB >> 16858676

Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands.

Anita B Bos1, Matejka Rebolj, J Dik F Habbema, Marjolein van Ballegooijen.   

Abstract

Although mass screening for cervical cancer has been operational for more than 2 decades in the Netherlands, 700 women are still diagnosed with this cancer each year (9 per 100,000). We investigated these cases, in order to evaluate opportunities to further increase the effectiveness of the programme. We analyzed the screening history of women diagnosed with cervical cancer between 1994-1997 using the Dutch national pathology file that includes cervical cytology and histological results. More than half of the cases did not have previous preventive cervical smears, and another 30% had never been invited to the programme because of their age. In the future, we estimate that two thirds of all Dutch women with invasive cervical cancer will be unscreened or under-screened, based on current screening participation of more than 70%. We conclude that increasing screening participation has much more potential for further reducing cervical cancer incidence than reducing the screening interval, increasing the age range or having a screening test with higher sensitivity.

Entities:  

Mesh:

Year:  2006        PMID: 16858676     DOI: 10.1002/ijc.22114

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Re: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

Authors:  Paolo Giorgi Rossi; Marco Zappa
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

2.  Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings.

Authors:  H N Pedersen; L W Smith; C Sarai Racey; D Cook; M Krajden; D van Niekerk; G S Ogilvie
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

3.  [Cervical cancer screening in Germany. Current status].

Authors:  V Schneider
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

4.  Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Authors:  Wina Verlaat; Barbara C Snoek; Daniëlle A M Heideman; Saskia M Wilting; Peter J F Snijders; Putri W Novianti; Annina P van Splunter; Carel F W Peeters; Nienke E van Trommel; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers; Folkert J van Kemenade; Johannes Berkhof; Mark A van de Wiel; Chris J L M Meijer; Renske D M Steenbergen
Journal:  Clin Cancer Res       Date:  2018-04-09       Impact factor: 12.531

5.  Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System.

Authors:  Sandi L Pruitt; Claudia L Werner; Eric K Borton; Joanne M Sanders; Bijal A Balasubramanian; Arti Barnes; Andrea C Betts; Celette Sugg Skinner; Jasmin A Tiro
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-05       Impact factor: 4.254

6.  Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.

Authors:  Charlotte H Lenselink; Roosmarie P de Bie; Dennis van Hamont; Judith M J E Bakkers; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

7.  Self-sampling of the vaginal fluid at home combined with high-risk HPV testing.

Authors:  K Sanner; I Wikström; A Strand; M Lindell; E Wilander
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

8.  Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.

Authors:  Hyun-Woong Cho; Jin Hwa Hong; Kyung Jin Min; Yung-Taek Ouh; Seok Ju Seong; Jun Hye Moon; Seong Hwan Cho; Jae Kwan Lee
Journal:  Cancer Res Treat       Date:  2020-12-24       Impact factor: 4.679

9.  A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results.

Authors:  Viola M J Verhoef; Maaike G Dijkstra; Remko P Bosgraaf; Albertus T Hesselink; Willem J G Melchers; Ruud L M Bekkers; Johannes Berkhof; Folkert J van Kemenade
Journal:  BMC Womens Health       Date:  2013-05-02       Impact factor: 2.809

Review 10.  Methods to increase participation in organised screening programs: a systematic review.

Authors:  Laura Camilloni; Eliana Ferroni; Beatriz Jimenez Cendales; Annamaria Pezzarossi; Giacomo Furnari; Piero Borgia; Gabriella Guasticchi; Paolo Giorgi Rossi
Journal:  BMC Public Health       Date:  2013-05-13       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.